Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study
Nobutaka Hattori(Juntendo University Hospital), Masahiro Nomoto(Saiseikai Ibaraki Hospital), Yuji Sasagawa, Yoshio Tsuboi(Fukuoka University), Akihiko Yamamoto
Cited by 80
Related Papers
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
|Nature Genetics|2000|2k
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
|The Journal of Cell Biology|2010|1.9k